NDC product
Allergy Plus Congestion Relief
NDC 51316-485 · CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED
Key facts
| Product NDC | 51316-485 |
|---|---|
| Proprietary name | Allergy Plus Congestion Relief |
| Nonproprietary name | Diphenhydramine HCl, Phenylephrine HCl |
| Substances | DIPHENHYDRAMINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC] |
| Marketing start | Aug 9, 2022 |
| Marketing end | Oct 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory